EDWARDS LIFESCIENCES CORPORATION
EW US28176E1082
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 46% | -42% | 3% | -2% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Chopra Daveen VP |
81.95 USD |
2,500 Sold |
204,865 USD |
25/08/2025 | 25/08/2025 |
| Wood Larry L PR |
78.06 USD |
8,950 Sold |
698,679 USD |
18/08/2025 | 18/08/2025 |
| Lippis Daniel J. VP |
79.46 USD |
4,114 Sold |
326,901 USD |
28/07/2025 | 28/07/2025 |
| Wood Larry L PR |
75.23 USD |
8,950 Sold |
673,268 USD |
16/06/2025 | 16/06/2025 |
| Zovighian Bernard J CEO |
77.32 USD |
967 Sold |
74,772 USD |
30/05/2025 | 03/06/2025 |
| Bobo Donald E Jr VP |
77.40 USD |
2,570 Sold |
198,911 USD |
02/06/2025 | 02/06/2025 |
| Zovighian Bernard J CEO |
77.21 USD |
16,099 Sold |
1,243,065 USD |
30/05/2025 | 30/05/2025 |
| Chopra Daveen VP |
75.08 USD |
1,500 Sold |
112,613 USD |
22/05/2025 | 22/05/2025 |
| Chopra Daveen VP |
75.08 USD |
1,500 Sold |
112,613 USD |
22/05/2025 | 22/05/2025 |
| Lippis Daniel J. VP |
74.42 USD |
330 Sold |
24,560 USD |
08/05/2025 | 09/05/2025 |